Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes
Get Live Data
5,450.00    -50.00 (-0.91%)
Bid:
5,400.00
Ask:
5,450.00
Spread: 50.00 (0.926%)
Market Cap: £137.76m
CAM Live PriceLast checked at - London Stock Exchange

Intraday Camellia Share Chart

Interim Management Statement

27 Mar 2008 15:09

Camellia PLC27 March 2008 Camellia Plc Interim Management Statement 27 March 2008 For Immediate Release Interim Management Statement This statement is made in accordance with Rule 4.3 of the UK Listing Authority'sDisclosure and Transparency Rules and covers the period from 1 January 2008. The majority of the group's operations have made a satisfactory start to 2008.There are however external factors that have affected some of our operationsduring the period under review although it is not expected that any of thesematters will have a material impact on the group's financial performance. Agriculture and Horticulture Kenya has suffered a prolonged drought. The disturbances in Kenya following theelections in December 2007 are to be regretted. It is hoped that the recentagreement between the two opposing factions will provide a peaceful solution tothe problems. The group suffered only minor damage and there were no injuries tostaff or their families during the period of increased tension. Production wasnot significantly affected by the unrest, but continues to be impacted by thedrought. India has also encountered dry weather conditions and decreased crops. Generally tea prices have been stronger than the previous year. High tea pricesin Kenya at the beginning of the year have recently moderated. The weakness of the US dollar will impact on the earnings of our operations inparticular in Kenya and Chile. Production costs have increased on account of higher energy and fertiliserprices. UK Operations The recent falls in global stock market values will inevitably lead toreductions in Duncan Lawrie Limited's investment management income. Costs willalso be higher due to the integration of the three operating subsidiaries.Duncan Lawrie Limited is not affected by the current banking crisis and has noexposure to the sub-prime mortgage market. Associates Siegfried Holding AG announced that, with effect from 1 January 2008, it hassigned long term cooperation agreements with Arena Pharmaceuticals. Inc. of SanDiego. Arena has acquired the pharmaceutical final dosage production unit fromSiegfried in Zofingen and Siegfried will act as Arena's outsourcing partner foractive pharmaceutical ingredients. Camellia Plc will announce its results for the year ended 31 December 2007 on 24April 2008. For further enquiries please contact Camellia PlcMalcolm Perkins, Chairman01622 74665527 March 2008 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
5th Feb 20257:00 amRNSTransaction in Own Shares
4th Feb 20258:29 amRNSTransaction in Own Shares
3rd Feb 20257:00 amRNSTransaction in Own Shares
31st Jan 20257:00 amRNSTransaction in Own Shares
30th Jan 20257:00 amRNSTrading Update
27th Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20257:00 amRNSTransaction in Own Shares
13th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSTransaction in Own Shares
3rd Jan 20257:00 amRNSTransaction in Own Shares
24th Dec 20247:00 amRNSTransaction in Own Shares
20th Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
17th Dec 20247:00 amRNSTransaction in Own Shares
9th Dec 20247:00 amRNSDirector/PDMR Shareholding
9th Dec 20247:00 amRNSTransaction in Own Shares
6th Dec 20247:00 amRNSDisposal
5th Dec 20247:00 amRNSDisposal
11th Nov 20248:06 amRNSSale of Bangladesh associate companies
31st Oct 202411:37 amRNSDisposal
25th Oct 202412:51 pmRNSHolding(s) in Company
17th Oct 20247:00 amRNSTrading Statement
6th Sep 202411:44 amRNSInterim Report 2024
6th Sep 20247:00 amRNSHalf-year Report
1st Jul 20247:00 amRNSDirector Changes
28th Jun 20241:00 pmRNSUpdate on BF&M Transaction
7th Jun 202411:14 amRNSResult of AGM
6th Jun 20247:00 amRNSTrading Update
1st May 202412:30 pmRNSAnnual Report & Notice of Annual General Meeting
29th Apr 20247:00 amRNSFinal Results
25th Apr 20247:00 amRNSDirector Changes
28th Mar 202412:11 pmRNSUpdate on BF&M disposal
4th Jan 20244:00 pmRNSRefocussing investments & Bardsley England update
27th Sep 202310:03 amRNSTrading Update
1st Sep 20235:21 pmRNSInterim Report 2023
1st Sep 20237:00 amRNSHalf-year Report
17th Jul 20237:00 amRNSDirector Changes
9th Jun 202312:08 pmRNSResult of AGM
8th Jun 20237:00 amRNSAGM Trading Statement
6th Jun 202312:00 pmRNSSale of holding in BF&M Limited
11th May 202311:04 amRNSAnnual Report and Notice of AGM
4th May 20237:00 amRNSFinal Results
20th Mar 20237:00 amRNSChange of Registered Office Address
8th Mar 20237:00 amRNSTrading Update
30th Jan 20237:00 amRNSBF&M Strategic Review Conclusion
10th Jan 20239:01 amRNSCompletion of Disposal of ACS&T
19th Dec 20227:00 amRNSDisposal of ACS&T and Relocation of Head Office
7th Dec 20227:00 amRNSTrading Update
22nd Nov 20222:38 pmRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.